Entourage Health Launches New Premium Color Cannabis Products
27 janv. 2022 08h00 HE
|
Entourage Health Corp.
TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Posts New Year 2022 Shareholder Newsletter
06 janv. 2022 08h15 HE
|
Entourage Health Corp.
TORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
24 déc. 2021 12h18 HE
|
Entourage Health Corp.
TORONTO, Dec. 24, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in 2022
15 déc. 2021 08h10 HE
|
Entourage Health Corp.
TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth
16 nov. 2021 07h00 HE
|
Entourage Health Corp.
Adult-Use net revenue for the quarter increased by 102% compared to last yearSales, general and administrative costs decreased by 16% compared to last yearStrategic acquisition of craft cultivator...
Entourage Health Closes Acquisition of Craft Cultivator CannTx Life Sciences Inc.
01 nov. 2021 07h05 HE
|
Entourage Health Corp.
Closing of deal merges craft brand Royal City Cannabis Co. into Entourage’s product portfolio Company enhances board with two new appointments from CannTx Life SciencesEntourage also completes...
Entourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 a.m. ET
19 oct. 2021 08h36 HE
|
Entourage Health Corp.
Fourth consecutive quarter of growth attributed to expanding market share and record salesCompany also completes amendments to its $39 million senior secured credit facility TORONTO, Oct. 19, 2021 ...
Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth
10 août 2021 07h05 HE
|
Entourage Health Corp.
Continued record sales of higher-margin products in all channels drives 29% gross marginFulfilled record purchase orders from every province, focusing on top-performing products resulting in a 159%...
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
20 juil. 2021 08h05 HE
|
Entourage Health Corp.
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), is pleased to announce preliminary...
WeedMD Added to Horizons Marijuana Life Sciences Index ETF
30 mars 2021 08h00 HE
|
WeedMD Rx Inc.
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...